Aethlon Medical (AEMD) Non Operating Investment Income (2022)

Aethlon Medical's (AEMD) quarterly Non Operating Investment Income came in at -$142121.0 in Q3 2022.

Aethlon Medical (AEMD) Non Operating Investment Income (2022) Analysis & Trends

Aethlon Medical's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$142121.0 for Q3 2022.

  • For the quarter ending Q3 2022, Non Operating Investment Income changed N/A year-over-year to -$142121.0; the trailing twelve-month figure through Sep 2023 stood at -$142121.0 (changed 0.0% YoY), and the FY2023 full-year result was -$142121.0, changed N/A from the prior year.
  • Non Operating Investment Income was -$142121.0 for Q3 2022 at Aethlon Medical.
  • Over the last five years, Non Operating Investment Income for AEMD reached as high as -$142121.0 in Q3 2022 and fell as low as -$142121.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Aethlon Medical 3.84 Mn -1.19 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -142,121.00
Sep 30, 2022 -142,121.00